We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 23.36%
This Fund
S&P 500
This Quarter Est. Return
+0.44%
1 Year Est. Return
+23.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33K
AUM Growth
-$107M
Cap. Flow
-$107M
Cap. Flow %
-322,946.95%
Top 10 Hldgs %
100%
Holding
2,163
New
1
Increased
–
Reduced
1
Closed
2,153

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$418K
2
GIS icon
General Mills
GIS
+$355K
3
WMT icon
Walmart Inc
WMT
+$303K
4
K
Kellanova
K
+$292K
5
PEP icon
PepsiCo
PEP
+$277K

Sector Composition

Rank Sector Weight
1 Healthcare 9.09%
2 Consumer Discretionary 0%
3 Consumer Staples 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYA icon
776
Liberty Global Class A
LBTYA
$3.35B
– –
-200
Closed -$6K
LBTYK icon
777
Liberty Global Class C
LBTYK
$3.27B
– –
-100
Closed -$3K
LCII icon
778
LCI Industries
LCII
$2.52B
– –
-369
Closed -$38K
LCNB icon
779
LCNB Corp
LCNB
$290M
– –
-283
Closed -$6K
LCUT icon
780
Lifetime Brands
LCUT
$202M
– –
-2,344
Closed -$43K
LEA icon
781
Lear
LEA
$7.26B
– –
-601
Closed -$85K
LEE icon
782
Lee Enterprises
LEE
$173M
– –
-200
Closed -$4K
LECO icon
783
Lincoln Electric
LECO
$14.1B
– –
-198
Closed -$18K
LEG icon
784
Leggett & Platt
LEG
$1.5B
– –
-1,000
Closed -$53K
LEN icon
785
Lennar Class A
LEN
$20.5B
– –
-1,156
Closed -$59K
LEN.B icon
786
Lennar Class B
LEN.B
$20.1B
– –
-619
Closed -$26K
LFCR icon
787
Lifecore Biomedical
LFCR
$163M
– –
-10,722
Closed -$159K
LFUS icon
788
Littelfuse
LFUS
$10.2B
– –
-400
Closed -$66K
LH icon
789
Labcorp
LH
$24.7B
– –
-821
Closed -$109K
LHX icon
790
L3Harris
LHX
$56.5B
– –
-423
Closed -$46K
LII icon
791
Lennox International
LII
$19B
– –
-563
Closed -$103K
LILA icon
792
Liberty Latin America Class A
LILA
$1.57B
– –
-937
Closed -$13K
LIVN icon
793
LivaNova
LIVN
$4.43B
– –
-1,410
Closed -$86K
LKQ icon
794
LKQ Corp
LKQ
$6.69B
– –
-2,902
Closed -$96K
LLY icon
795
Eli Lilly
LLY
$1.07T
– –
-1,399
Closed -$115K
LMAT icon
796
LeMaitre Vascular
LMAT
$2.26B
– –
-2,177
Closed -$68K
LMNR icon
797
Limoneira
LMNR
$242M
– –
-5,213
Closed -$123K
LMT icon
798
Lockheed Martin
LMT
$134B
– –
-600
Closed -$167K
LNC icon
799
Lincoln National
LNC
$7.88B
– –
-800
Closed -$54K
LNN icon
800
Lindsay Corp
LNN
$1.17B
– –
-1,429
Closed -$128K
30 31
32
33 34

Similar funds

CRAM
Claren Road Asset Management New York $891K AUM
ABFS
Appropriate Balance Financial Services Bellevue, Washington $2.01M AUM 19.83% 1-Year Est. Return
VHS
Vitol Holding (Switzerland) Geneva, Switzerland $4.12M AUM
ACM
Addison Clark Management Stamford, Connecticut $5M AUM 6.65% 1-Year Est. Return
SIM
Summitview Investment Management Grand Cayman, Cayman Islands $6.18M AUM
MC
Mitra Capital Boston, Massachusetts $10.2M AUM 51.14% 1-Year Est. Return
TU
Teilinger USA Houston, Texas $12.7M AUM
ASB
Amundi Smith Breeden Durham, North Carolina $18.8M AUM

Acrospire Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Acrospire Investment Management held 2,163 positions worth $33K, down 100% from $107M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Acrospire Investment Management withdrew a net $107M in Q3 2017, closing 2,153 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $418K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Acrospire Investment Management's biggest Q3 2017 reduction was Patheon N.V., cutting an estimated $3.49K.
  • Acrospire Investment Management fully exited Procter & Gamble in Q3 2017, selling an estimated $418K.
  • Acrospire Investment Management's ten largest holdings make up 100% of its $33K portfolio in Q3 2017.
  • Acrospire Investment Management opened 1 new position and closed 2,153 in Q3 2017.
  • Acrospire Investment Management's portfolio value fell 100% quarter-over-quarter to $33K.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.